Trial Profile
Phase I Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 05 May 2015
Price :
$35
*
At a glance
- Drugs Tenofovir (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors CONRAD
- 30 Apr 2015 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 24 Sep 2014 New trial record